Two grants will be awarded in 2023 to accelerate initiatives that are focused on improving access to precision oncology care and tackling inequalities for children with cancer around the world
The 2023 awards will be awarded to innovative programs tackling access to biomarker testing in the following cancer types:
Pediatric Cancers (solid tumours) that are known to harbor rare, actionable genomic alterations. Types of genomic alterations can include mutations (e.g., KRAS, BRAF, EGFR), gene fusions (e.g., ROS1, NTRK, FGFR, RET), and many more.
Apply for the Precision Oncology Patient Innovation Awards
Step 1: Download the application
Step 2: Submit a proposal
View more details on how to apply
Next Important Date
June 16, 2023 – Deadline for initial applications
Applications will be reviewed by an independent, non-Bayer review panel composed of experienced representatives from the clinical and patient advocacy communities.
Duration of Award: 1 Year
Award Value: Two awards in the amount of $50,000 USD each.
Find out more https://www.precisiononcologyawards.com/